title: No prognostic impact of P2RY8-CRLF2 fusion in intermediate cytogenetic risk childhood B-cell acute lymphoblastic leukaemia.
authors.forename: Janusz
authors.initials: J
authors.lastname: Krawczyk
authors.forename: Karl
authors.initials: K
authors.lastname: Haslam
authors.forename: Paul
authors.initials: P
authors.lastname: Lynam
authors.forename: Johanna
authors.initials: J
authors.lastname: Kelly
authors.forename: Lorna
authors.initials: L
authors.lastname: Storey
authors.forename: Aengus
authors.initials: A
authors.lastname: O'Marcaigh
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Langabeer
authors.forename: Owen P
authors.initials: OP
authors.lastname: Smith
mesh_terms: D002648:Child; D015331:Cohort Studies; D050939:Gene Fusion / Q000235:genetics*; D006801:Humans; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics*; D011379:Prognosis; D060888:Real-Time Polymerase Chain Reaction; D018121:Receptors, Cytokine / Q000235:genetics* / Q000378:metabolism; D058470:Receptors, Purinergic P2Y / Q000235:genetics* / Q000378:metabolism; D012307:Risk Factors
chemical_list: C498762:CRLF2 protein, human; C578279:P2RY8 protein, human; D018121:Receptors, Cytokine; D058470:Receptors, Purinergic P2Y